Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017

Haiti is striving for zero local malaria transmission by the year 2025. Chloroquine remains the first-line treatment, and sulfadoxine/pyrimethamine (SP) has been used for mass drug-administration pilot programs. In March 2016, nationwide molecular surveillance was initiated to assess molecular resis...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Eric Rogier, Camelia Herman, Curtis S. Huber, Karen E.S. Hamre, Baby Pierre, Kimberly E. Mace, Jacquelin Présumé, Gina Mondélus, Ithamare Romilus, Tamara Elismé, Thomas P. Eisele, Thomas Druetz, Alexandre Existe, Jacques Boncy, Jean F. Lemoine, Venkatachalam Udhayakumar, Michelle A. Chang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Centers for Disease Control and Prevention 2020-05-01
Sarja:Emerging Infectious Diseases
Aiheet:
Plasmodium falciparum
Haiti
drug resistance
chloroquine
sulfadoxine
pyrimethamine
Linkit:https://wwwnc.cdc.gov/eid/article/26/5/19-0556_article
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia